Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,759 | 396 | 96.7% |
| Entertainment | $221.76 | 8 | 3.2% |
| Education | $12.21 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,901 | 112 | $0 (2024) |
| Janssen Biotech, Inc. | $648.32 | 39 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $543.80 | 34 | $0 (2024) |
| Romark Laboratories, LC | $448.96 | 29 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $434.46 | 32 | $0 (2024) |
| PFIZER INC. | $339.46 | 15 | $0 (2024) |
| GENZYME CORPORATION | $253.13 | 7 | $0 (2024) |
| Allergan, Inc. | $228.41 | 16 | $0 (2020) |
| IRONWOOD PHARMACEUTICALS, INC | $173.84 | 10 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $169.31 | 10 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,405 | 63 | ABBVIE INC. ($520.00) |
| 2023 | $815.18 | 37 | ABBVIE INC. ($340.68) |
| 2022 | $445.19 | 29 | ABBVIE INC. ($278.93) |
| 2021 | $444.79 | 31 | AbbVie Inc. ($193.71) |
| 2020 | $402.09 | 27 | Janssen Biotech, Inc. ($82.37) |
| 2019 | $1,350 | 81 | AbbVie, Inc. ($243.18) |
| 2018 | $1,040 | 66 | Romark Laboratories, LC ($178.34) |
| 2017 | $1,090 | 72 | Romark Laboratories, LC ($160.40) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $22.92 | General |
| Category: GI | ||||||
| 11/19/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: LIVER DISEASE | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 09/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: LIVER DISEASE | ||||||
| 09/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Immunology | ||||||
| 08/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,649 | 1,889 | $1.5M | $265,053 |
| 2022 | 17 | 1,598 | 1,819 | $1.4M | $263,086 |
| 2021 | 19 | 1,653 | 1,854 | $1.4M | $272,759 |
| 2020 | 18 | 1,360 | 1,543 | $1.2M | $203,821 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 124 | 139 | $255,925 | $40,487 | 15.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 144 | 145 | $291,250 | $37,524 | 12.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 93 | 94 | $282,000 | $36,390 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 318 | $67,734 | $32,650 | 48.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 76 | 76 | $152,000 | $20,620 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 203 | 248 | $35,712 | $17,517 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $30,832 | $12,473 | 40.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 18 | 19 | $38,000 | $12,309 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 102 | 188 | $26,775 | $11,735 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $23,220 | $8,576 | 36.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 19 | 19 | $38,000 | $6,560 | 17.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 54 | 55 | $14,914 | $6,006 | 40.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $30,000 | $4,222 | 14.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 94 | 98 | $8,526 | $4,137 | 48.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 43 | $64,000 | $4,063 | 6.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 79 | 79 | $11,771 | $3,992 | 33.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $65,000 | $2,750 | 4.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $16,800 | $2,217 | 13.2% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 66 | 72 | $637.92 | $355.68 | 55.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 19 | $798.00 | $343.23 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 15 | $225.00 | $126.00 | 56.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 131 | 149 | $282,475 | $48,666 | 17.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 122 | 122 | $263,250 | $37,005 | 14.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 108 | 108 | $216,000 | $29,601 | 13.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 73 | 74 | $221,475 | $28,916 | 13.1% |
About Dr. Alan Plumer, M.D
Dr. Alan Plumer, M.D is a Gastroenterology healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760405245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Plumer, M.D has received a total of $6,993 in payments from pharmaceutical and medical device companies, with $1,405 received in 2024. These payments were reported across 406 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,759).
As a Medicare-enrolled provider, Plumer has provided services to 6,260 Medicare beneficiaries, totaling 7,105 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Goshen, NY
- Active Since 07/25/2006
- Last Updated 09/27/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1760405245
Products in Payments
- STELARA (Biological) $509.78
- SKYRIZI (Biological) $442.58
- LINZESS (Drug) $371.86
- XELJANZ (Drug) $339.46
- Alinia Tablets 500mg 30 count bottle (Drug) $338.74
- RINVOQ (Biological) $326.82
- XIFAXAN (Drug) $309.81
- TRULANCE (Drug) $260.01
- Creon (Drug) $259.18
- DUPIXENT (Biological) $253.13
- Entyvio (Biological) $225.52
- VIBERZI (Drug) $207.62
- Humira (Biological) $184.49
- TREMFYA (Drug) $171.37
- Trulance (Drug) $169.31
- HUMIRA (Biological) $159.24
- Amitiza (Drug) $155.97
- NASCOBAL (Drug) $153.98
- ZENPEP (Drug) $117.55
- VOQUEZNA (Drug) $117.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Goshen
Dr. Salim Jaffer, Md, MD
Gastroenterology — Payments: $25,717
Lance Siegel, M.d, M.D
Gastroenterology — Payments: $15,896
David Ellis, M.d, M.D
Gastroenterology — Payments: $15,881
Dr. Sadat Rashid, M.d, M.D
Gastroenterology — Payments: $9,025
Dr. Ross Heil, D.o, D.O
Gastroenterology — Payments: $8,682
Alan Goldfischer, M.d, M.D
Gastroenterology — Payments: $3,542